Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia Academic Article uri icon

Overview

MeSH Major

  • Hematologic Neoplasms
  • Picornaviridae Infections
  • Respiratory Tract Infections
  • Rhinovirus

publication date

  • June 18, 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1080/10428194.2018.1468893

PubMed ID

  • 29963936

Additional Document Info

start page

  • 1

end page

  • 4